lepr antagonist peptide allo aca Search Results


leptin receptor antagonist  (Biosynth Carbosynth)
93
Biosynth Carbosynth leptin receptor antagonist
mRNA levels of <t>NOTCH1</t> <t>receptor,</t> JAGGED1 ligand, IL-1β and IL-1R, <t>LEPTIN,</t> ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the γ-secretase inhibitor DAPT treatment group in CRC tumors. Levels of mRNA determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments. * p < 0.05, ** p < 0.01, and ***p < 0.001.
Leptin Receptor Antagonist, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lepr+antagonist+peptide+allo+aca/pmc10751088-39-30-38?v=Biosynth+Carbosynth
Average 93 stars, based on 1 article reviews
leptin receptor antagonist - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

Image Search Results


mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the γ-secretase inhibitor DAPT treatment group in CRC tumors. Levels of mRNA determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments. * p < 0.05, ** p < 0.01, and ***p < 0.001.

Journal: Turkish Journal of Biology

Article Title: Targeting of Notch, IL-1, and leptin has therapeutic potential in xenograft colorectal cancer

doi: 10.55730/1300-0152.2663

Figure Lengend Snippet: mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the γ-secretase inhibitor DAPT treatment group in CRC tumors. Levels of mRNA determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments. * p < 0.05, ** p < 0.01, and ***p < 0.001.

Article Snippet: γ-secretase inhibitor DAPT (GSI-IX) was purchased from Selleckchem (Cat No. 208255-80-5, Houston, TX, USA), IL-1 receptor antagonist Anakinra was purchased from TOCRIS (Cat No. 185413-30-3, Minneapolis, MN, USA) and the leptin receptor antagonist, Allo aca, was purchased from Peptides international (Cat No. PCS-32627-PI, Louisville, Kentucky, USA).

Techniques: Quantitative RT-PCR, Control, Derivative Assay

mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the LEPTIN receptor antagonist Allo aca treatment group in CRC tumors. Levels of mRNA were determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments: * p < 0.05, ** p < 0.01, and ***p < 0.001.

Journal: Turkish Journal of Biology

Article Title: Targeting of Notch, IL-1, and leptin has therapeutic potential in xenograft colorectal cancer

doi: 10.55730/1300-0152.2663

Figure Lengend Snippet: mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the LEPTIN receptor antagonist Allo aca treatment group in CRC tumors. Levels of mRNA were determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments: * p < 0.05, ** p < 0.01, and ***p < 0.001.

Article Snippet: γ-secretase inhibitor DAPT (GSI-IX) was purchased from Selleckchem (Cat No. 208255-80-5, Houston, TX, USA), IL-1 receptor antagonist Anakinra was purchased from TOCRIS (Cat No. 185413-30-3, Minneapolis, MN, USA) and the leptin receptor antagonist, Allo aca, was purchased from Peptides international (Cat No. PCS-32627-PI, Louisville, Kentucky, USA).

Techniques: Quantitative RT-PCR, Control, Derivative Assay

mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the IL1 receptor antagonist Anakinra treatment group in CRC tumors. Levels of mRNA were determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments: * p < 0.05, ** p < 0.01, and ***p < 0.001.

Journal: Turkish Journal of Biology

Article Title: Targeting of Notch, IL-1, and leptin has therapeutic potential in xenograft colorectal cancer

doi: 10.55730/1300-0152.2663

Figure Lengend Snippet: mRNA levels of NOTCH1 receptor, JAGGED1 ligand, IL-1β and IL-1R, LEPTIN, ObRb, VEGF-A, VEGFR1, and VEGFR2 (A-B-C-D-E-F-G-H-I respectively) in the IL1 receptor antagonist Anakinra treatment group in CRC tumors. Levels of mRNA were determined by real-time RT-PCR. β-actin was used as an internal control. Data is shown as mean ± SE derived from a minimum of three independent experiments: * p < 0.05, ** p < 0.01, and ***p < 0.001.

Article Snippet: γ-secretase inhibitor DAPT (GSI-IX) was purchased from Selleckchem (Cat No. 208255-80-5, Houston, TX, USA), IL-1 receptor antagonist Anakinra was purchased from TOCRIS (Cat No. 185413-30-3, Minneapolis, MN, USA) and the leptin receptor antagonist, Allo aca, was purchased from Peptides international (Cat No. PCS-32627-PI, Louisville, Kentucky, USA).

Techniques: Quantitative RT-PCR, Control, Derivative Assay